Cargando…
Crosstalk between gut microbiota and antidiabetic drug action
Type 2 diabetes (T2D) is a disorder characterized by chronic inflated blood glucose levels (hyperglycemia), at first due to insulin resistance and unregulated insulin secretion but with tendency towards global spreading. The gut microbiota is recognized to have an influence on T2D, although surveys...
Autores principales: | Kyriachenko, Yevheniia, Falalyeyeva, Tetyana, Korotkyi, Oleksandr, Molochek, Nataliia, Kobyliak, Nazarii |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422856/ https://www.ncbi.nlm.nih.gov/pubmed/30891151 http://dx.doi.org/10.4239/wjd.v10.i3.154 |
Ejemplares similares
-
Pathophysiological role of host microbiota in the development of obesity
por: Kobyliak, Nazarii, et al.
Publicado: (2016) -
Effect of a specific Escherichia coli Nissle 1917 strain on minimal/mild hepatic encephalopathy treatment
por: Manzhalii, Elina, et al.
Publicado: (2022) -
Antimicrobial activity of dietary supplements based on bacterial lysate of Lactobacillus rhamnosus DV
por: Penchuk, Yurii, et al.
Publicado: (2023) -
Short-term periodic consumption of multiprobiotic from childhood improves insulin sensitivity, prevents development of non-alcoholic fatty liver disease and adiposity in adult rats with glutamate-induced obesity
por: Savcheniuk, Oleksandr, et al.
Publicado: (2014) -
Obeticholic Acid: A New Era in the Treatment of Nonalcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2018)